BP004760: Human HLA-A*02:01&B2M&GP100 (YLEPGPVTA) Tetramer Protein with the C-His-Avi Tag

Source: The recombinant Human HLA-A*02:01&B2M&GP100 (YLEPGPVTA) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and YLEPGPVTA peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human HLA-A*02:01&B2M&GP100 (YLEPGPVTA) Tetramer protein with the C-His-Avi tag at 2 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Anti-HLA-A*02:01&B2M&GP100 (YLEPGPVTA) Antibody protein with the C-hFc tag with the EC50 of 5.6 ng/ml determined by ELISA (QC Test). The affinity constant of 0.196 nM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP005412: Human HLA-A*02:01&B2M&GP100 (YLEPGPVTA) Monomer Protein with the C-His-Avi Tag

Source: The recombinant Human HLA-A*02:01&B2M&GP100 (YLEPGPVTA) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and YLEPGPVTA peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human HLA-A*02:01&B2M&GP100 (YLEPGPVTA) Monomer protein with the C-His-Avi tag at 2 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Anti-HLA-A*02:01&B2M&GP100 (YLEPGPVTA) Antibody protein with the C-hFc tag with the EC50 of 9.1 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP003128: Human HLA-A*02:01&B2M&CMV pp65 (NLVPMVATV) Tetramer Protein with the C-His-Avi Tag

Source: The recombinant Human HLA-A*02:01&B2M&CMV pp65 (NLVPMVATV) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and NLVPMVATV peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP003130: Human HLA-A*02:01&B2M&CMV pp65 (NLVPMVATV) Monomer Protein with the C-His-Avi Tag

Source: The recombinant Human HLA-A*02:01&B2M&CMV pp65 (NLVPMVATV) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and NLVPMVATV peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP004280: Human HLA-A*02:01&B2M&AFP (PLFQVPEPV) Tetramer Protein with the C-His-Avi Tag

Source: The recombinant Human HLA-A*02:01&B2M&AFP (PLFQVPEPV) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and PLFQVPEPV peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP004281: Human HLA-A*02:01&B2M&AFP (PLFQVPEPV) Monomer Protein with the C-His-Avi Tag

Source: The recombinant Human HLA-A*02:01&B2M&AFP (PLFQVPEPV) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and PLFQVPEPV peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP004271: Human HLA-A*02:01&B2M&AFP (FMNKFIYEI) Tetramer Protein with the C-His-Avi Tag

Source: The recombinant Human HLA-A*02:01&B2M&AFP (FMNKFIYEI) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and FMNKFIYEI peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human HLA-A*02:01&B2M&AFP (FMNKFIYEI) Tetramer protein with the C-His-Avi tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-HLA-A*02:01&B2M&AFP (FMNKFIYEI) Antibody protein with the C-hFc tag with the EC50 of 3.9 ng/ml determined by ELISA (QC Test). The affinity constant of 0.111 uM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP004266: Human HLA-A*02:01&B2M&AFP (FMNKFIYEI) Monomer Protein with the C-His-Avi Tag

Source: The recombinant Human HLA-A*02:01&B2M&AFP (FMNKFIYEI) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and FMNKFIYEI peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human HLA-A*02:01&B2M&AFP (FMNKFIYEI) Monomer protein with the C-His-Avi tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-HLA-A*02:01&B2M&AFP (FMNKFIYEI) Antibody protein with the C-hFc tag with the EC50 of 1.9 ng/ml determined by ELISA (QC Test). The affinity constant of 0.923 uM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP004092: Human HLA-A*01:01&B2M&MAGE-A3 (EVDPIGHLY) Tetramer Protein with the C-His-Avi Tag

Source: The recombinant Human HLA-A*01:01&B2M&MAGE-A3 (EVDPIGHLY) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*01:01),Ile21-Met119(B2M)and EVDPIGHLY peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP004100: Human HLA-A*01:01&B2M&MAGE-A3 (EVDPIGHLY) Monomer Protein with the C-His-Avi Tag

Source: The recombinant Human HLA-A*01:01&B2M&MAGE-A3 (EVDPIGHLY) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*01:01),Ile21-Met119(B2M)and EVDPIGHLY peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.